Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELQZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,589
Award facts
- Contract value 100% obligated
- $10,588.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, awarded on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors responsible for supplying comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. No set-aside designation was applied to this award, reflecting the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's product portfolio under the PPV-G GEN V contract encompasses branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs across military healthcare operations. The company's underlying IDC, awarded November 13, 2025, carries a $499,999,999 ceiling value with a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. This delivery order award demonstrates the contractor's established performance executing the diverse and specialized pharmaceutical requirements essential to federal military medical system operations.
Quick answers
Who was awarded contract SPE2DU26FELQZ?
SPE2DU26FELQZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FELQZ worth?
The government has obligated $10,589 on SPE2DU26FELQZ.
Is contract SPE2DU26FELQZ an order under another contract?
Yes. SPE2DU26FELQZ is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQZ competed?
The extent of competition for SPE2DU26FELQZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award